Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care [0.03%]
新兴胰岛素技术在基层医疗中糖尿病起始和强化胰岛素治疗中的作用
Stephen A Brunton,Davida F Kruger,Martha M Funnell
Stephen A Brunton
In Brief This article explores some of the reasons for the delay in insulin initiation in primary care and evaluates new approaches to insulin therapy that may address these barriers and, therefore, improve insulin use by primary care provi...
Paula M Trief,Donald Cibula,Elaine Rodriguez et al.
Paula M Trief et al.
In Brief Incorrect administration of insulin (e.g., too little, too much, or at wrong times) can result in transient and serious hypo- and hyperglycemia, wide glycemic excursions, and diabetic ketoacidosis. The authors systematically assess...
Standards of Medical Care in Diabetes-2016 Abridged for Primary Care Providers [0.03%]
糖尿病诊疗标准(2016年版)摘录（基层医疗篇）
American Diabetes Association
American Diabetes Association
A Call to Action: Eliminating Diabetes Disparities in Native Communities [0.03%]
行动起来：消除_NATIVE_社区的糖尿病差异
Kelli Begay,Gina Gavlak,LaShawn McIver
Kelli Begay
Rani Polak,Edward M Phillips,Amy Campbell
Rani Polak
Minu M George,Alejandro R Ruiz-Elizalde,Joni K Beck
Minu M George
Metformin-Associated Lactic Acidosis in a Patient With Normal Renal Function [0.03%]
肾功能正常的患者出现二甲双胍相关性乳酸酸中毒
Barry A Kriegsman,B Guirguis Hanna
Barry A Kriegsman
Redesigning the Traditional Community Health Screening Model to Provide Blood Glucose Screening and Interdisciplinary Health Education [0.03%]
重构传统社区健康筛查模式以提供血糖筛查和跨学科健康教育
Kimberly C McKeirnan,Shannon G Panther,Julie M Akers
Kimberly C McKeirnan
Self-Reported Gastrointestinal Symptoms in Type 2 Diabetes Improve With an Intensive Lifestyle Intervention: Results From the Action for Health in Diabetes (Look AHEAD) Clinical Trial [0.03%]
Look AHEAD 研究：生活干预可改善2型糖尿病患者的自报胃肠症状
Rebecca H Neiberg,Jared J Rejeski,William B Applegate et al.
Rebecca H Neiberg et al.
In Brief This article reports on an investigation of whether an intensive lifestyle intervention (ILI) would reduce gastrointestinal symptoms over 4 years of follow-up for participants in the Action for Health in Diabetes (Look AHEAD) trial...